Based on this, we plan to systematically explore the regulatory role of ZC3H15 on the AKT-mTOR pathway in different tumor types, as well as the tissue-specific differences and molecular basis of this regulatory mechanism in subsequent studies. This evidence concerns the gene AKT1 and neoplasm.